|
Volumn 28, Issue 6, 2004, Pages 440-444
|
Potential validity of thermolabile drugs outside the preservation conditions recommended by the manufacturer;Posible validez de medicamentos termolábiles fuera de las condiciones de conservación recomendadas por el fabricante
|
Author keywords
Expiry; Room temperature; Stability; Thermolabile drugs
|
Indexed keywords
ABCIXIMAB;
AGALSIDASE BETA;
ALBUMIN;
ALBUMINA HUMANA;
ALEUDRINA;
ALTEPLASE;
AMPHOTERICIN B;
AMPHOTERICIN B LIPID COMPLEX;
ANATOXA TE;
ANATOXA TEDI;
ANBIN;
ANTITHROMBIN III;
ASPARAGINASE;
ATOSIBAN;
ATRACURIUM BESILATE;
BASILIXIMAB;
BERACTANT;
BETA1A INTERFERON;
BLEOMICINA;
BLEOMYCIN;
BLOOD CLOTTING FACTOR 8;
BLOOD CLOTTING FACTOR 9 CONCENTRATE;
BOTULINUM TOXIN A;
BOTULINUM TOXIN B;
CAFERGOT;
CALCITONIN;
CALCITONINA;
CASPOFUNGIN;
CEFONICID;
CELSIOR;
CHLORAMBUCIL;
CLADRIBINE;
COLIRCURSI FLUOTEST;
COLIRCUSI FENILEFRINA;
DESMOPRESSIN;
DESMOPRESSIN DIACETATE;
DORNASE ALFA;
DOXORUBICIN;
DOXORUBICINA;
DOXYCYCLINE;
DROTRECOGIN;
ENISON;
EPTIFIBATIDE;
ETANERCEPT;
FANHDI;
FARMIBLASTINA;
FLEBOGAMMA LP;
FS 069;
FUNGIZONA;
GAMMA ANTIHEPATITIS B;
GENOTONORM MINIQUICK;
GLATIRAMER;
GLUCAGON GEN HIPOKIT;
HAEMOPHILUS INFLUENZAE TYPE B VACCINE;
HEPATITIS A VACCINE;
HUMULINA;
IMIGLUCERASE;
IMMUCYSTI;
IMMUNINE STIM;
IMMUNOGLOBULIN;
IMMUNOGLOBULIN G;
INFLIXIMAB;
INSULIN GLARGINE;
INSULIN LISPRO;
INTERFERON BETA SERINE;
ISOPHANE INSULIN;
LEVOSIMENDAN;
LOPINAVIR PLUS RITONAVIR;
LYSSUMAN;
MELPHALAN;
METHYLERGOMETRINE MALEATE;
MICONAZOLE;
MIOFLEX;
MIXTARD HM;
NAVELBINE;
NEUTRAL INSULIN;
NITROUREAN;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
OCTREOTIDE;
ORTHOCLONE OKT 3;
PALIVIZUMAB;
PANCURONIUM BROMIDE;
PEGINTERFERON ALPHA2A;
PEGINTERFERON ALPHA2B;
PNEUMOCOCCUS VACCINE;
PROSTAGLANDIN E1;
PROSTAGLANDIN E2;
PROTAMINA;
PROTHROMPLEX IMMUNO TIM4;
RAPAMYCIN;
RASBURICASE;
RECOMBINANT ALPHA2A INTERFERON;
RECOMBINANT ALPHA2B INTERFERON;
RECOMBINANT BLOOD CLOTTING FACTOR 7A;
RECOMBINANT BLOOD CLOTTING FACTOR 8;
RECOMBINANT BLOOD CLOTTING FACTOR 9;
RECOMBINANT ERYTHROPOIETIN;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RECOMBINANT HEPATITIS B VACCINE;
RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
RECOMBINANT INTERLEUKIN 2;
RECOMBINANT THYROTROPIN;
RISPERIDONE;
RITONAVIR;
RITUXIMAB;
ROCURONIUM;
SAQUINAVIR;
SOLUVIT;
STREPTOKINASE;
TETRACOSACTIDE;
THIOTEPA;
THYMOCYTE ANTIBODY;
TISSUCOL DUO;
TOBRAMYCIN;
TRASTUZUMAB;
TUBERCULINA PPD RT 23;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VAC ANTIRRABICA;
VARIDASA TOPICA;
VARITEC;
VIBRAVENOSA;
VINBLASTINA;
VIPERFAV;
VITALIPID ADULTO;
VITALIPID INF;
DECISION MAKING;
DRUG INFORMATION;
DRUG STABILITY;
DRUG STORAGE;
FREEZING;
HOSPITAL PHARMACY;
HUMAN;
PHARMACIST;
PRACTICE GUIDELINE;
PROFESSIONAL PRACTICE;
REVIEW;
ROOM TEMPERATURE;
TEMPERATURE DEPENDENCE;
THERMOSTABILITY;
DRUG STABILITY;
DRUG STORAGE;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
PHARMACOLOGY, CLINICAL;
PHARMACY SERVICE, HOSPITAL;
PRESERVATION, BIOLOGICAL;
REFRIGERATION;
TEMPERATURE;
|
EID: 13444304359
PISSN: 11306343
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (10)
|
References (8)
|